ProQR Therapeutics N.V. Adjustments For Unrealised Foreign Exchange Losses Gains
ProQR Therapeutics N.V. (PRQR) reported Adjustments For Unrealised Foreign Exchange Losses Gains of EUR 206.00 thousand for the 3-month period ending 2021-09-30, per its 6-K filed 2021-11-04.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2021-11-04
- ProQR Therapeutics N.V. adjustments for unrealised foreign exchange losses gains for the quarter ending 2021-09-30 was 206.00K EUR.
- ProQR Therapeutics N.V. adjustments for unrealised foreign exchange losses gains for the quarter ending 2021-06-30 was -141.00K EUR.
- ProQR Therapeutics N.V. adjustments for unrealised foreign exchange losses gains for the quarter ending 2020-12-31 was -206.00K EUR.
- ProQR Therapeutics N.V. adjustments for unrealised foreign exchange losses gains for the quarter ending 2020-09-30 was -255.00K EUR, a 272.30% decline year-over-year.
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 3 month | Adjustments For Unrealised Foreign Exchange Losses Gains 6 month | Adjustments For Unrealised Foreign Exchange Losses Gains 9 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|---|---|
| 2021-09-30 | 206.00K EUR 6-K · filed 2021-11-04 | 65.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | 461.00K EUR 6-K · filed 2021-11-04 | |
| 2021-06-30 | -141.00K EUR 6-K · filed 2021-08-05 | 255.00K EUR 6-K · filed 2021-08-05 | ||
| 2020-12-31 | -206.00K EUR 6-K · filed 2021-02-25 | -461.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | -596.00K EUR derived: sum of 3 quarters · filed 2021-11-04 | -340.00K EUR 20-F · filed 2021-03-24 |
| 2020-09-30 | -255.00K EUR 6-K · filed 2021-11-04 | -390.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | -134.00K EUR 6-K · filed 2021-11-04 | -213.00K EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -135.00K EUR 6-K · filed 2021-08-05 | 121.00K EUR 6-K · filed 2021-08-05 | 42.00K EUR derived: sum of 3 quarters · filed 2021-08-05 | 190.00K EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 256.00K EUR 6-K · filed 2020-05-07 | 177.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | 325.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | 287.00K EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | -79.00K EUR 6-K · filed 2021-02-25 | 69.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | 31.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | 43.00K EUR 20-F · filed 2021-03-24 |
| 2019-09-30 | 148.00K EUR 6-K · filed 2020-11-16 | 110.00K EUR derived: sum of 2 quarters · filed 2020-11-16 | 122.00K EUR 6-K · filed 2020-11-16 | 109.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -38.00K EUR 6-K · filed 2020-08-06 | -26.00K EUR 6-K · filed 2020-08-06 | -39.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -43.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | 12.00K EUR 6-K · filed 2020-05-07 | -1.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -5.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | 10.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | -13.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | -17.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -2.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -28.00K EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | -4.00K EUR 6-K · filed 2019-11-12 | 11.00K EUR derived: sum of 2 quarters · filed 2019-11-12 | -15.00K EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | 15.00K EUR 6-K · filed 2019-08-07 | -11.00K EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | 151.00K EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | 63.00K EUR 6-K · filed 2018-08-08 | 65.00K EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | -16.00K EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | 1.00K EUR 20-F · filed 2018-03-30 |